Cent Eur J Public Health 2026, 34(3):171-176 | DOI: 10.21101/cejph.a8451

Impact of COVID-19 on breast cancer screening: time series analysis of pre-pandemic, pandemic and post-pandemic periods

Gökhan Mert Özyurt1, Sarhun Zirek1, Duygu Kolukisa2, Cemil Yüksel3, Mutlay Keskin4
1 Department of Radiology, Mersin City Hospital, Mersin, Türkiye
2 Department of Pathology, Mersin City Hospital, Mersin, Türkiye
3 Department of Oncology, Mersin City Hospital, Mersin, Türkiye
4 Department of Nuclear Medicine, Mersin City Hospital, Mersin, Türkiye

Objectives: This study aimed to evaluate the impact of the COVID-19 pandemic on breast cancer screening activity, cancer detection rates, and stage at diagnosis by comparing pre-pandemic, pandemic, and post-pandemic periods.

Methods: This retrospective cross-sectional study included women who underwent breast cancer screening between March 2018 and February 2024. The study period was divided into three phases: pre-pandemic (March 2018 – February 2020), pandemic (March 2020 – February 2022), and post-pandemic (March 2022 – February 2024). Screening activity, including mammography and breast ultrasonography examinations, cancer detection rates, age at diagnosis, tumour size, and stage distributions were evaluated.

Results: A total of 102,833 women underwent breast cancer screening during the study period. Significant differences were observed in the numbers of screened women, mammography examinations, ultrasound examinations, and breast cancers detected across the study periods (all p < 0.001). The cancer detection rate increased from 10.64 per 1,000 screened women in the pre-pandemic period to 12.68 during the pandemic and 16.32 in the post-pandemic period (p < 0.001). Early-stage diagnoses decreased from 84% to 72%, whereas advanced-stage diagnoses increased from 16% to 28% (p = 0.002). The proportion of metastatic disease increased from 5.6% to 22% (p = 0.028). No significant differences were observed in age at diagnosis (p = 0.896), tumour size (p = 0.201), or T stage distribution (p = 0.519).

Conclusions: The COVID-19 pandemic substantially affected breast cancer screening and diagnosis. Although screening activity declined during the pandemic, cancer detection rates increased and a significant shift toward advanced-stage and metastatic disease was observed in the post-pandemic period. Maintaining resilient and accessible breast cancer screening services during future healthcare crises is essential to minimize diagnostic delays and improve patient outcomes.

Keywords: breast cancer, cancer screening, COVID-19

Received: October 29, 2024; Revised: August 6, 2026; Accepted: August 6, 2026; Published: September 30, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Özyurt GM, Zirek S, Kolukisa D, Yüksel C, Keskin M. Impact of COVID-19 on breast cancer screening: time series analysis of pre-pandemic, pandemic and post-pandemic periods. Cent Eur J Public Health. 2026;34(3):171-176. doi: 10.21101/cejph.a8451.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 31.3.2027

    References

    1. Ak N, Tuz Z, Aydin E, Ferhatoglu F, Sari M, Paksoy N, et al. The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients. Turk J Med Sci. 2023;54(1):229-38.
    2. Ginsburg O, Yip CH, Brooks A, Cabanes A, Caleffi M, Dunstan Yataco JA, et al. Breast cancer early detection: a phased approach to implementation. Cancer. 2020;126(10):2379-93.
    3. Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020 Nov 4:371:m4087. doi: 10.1136/bmj.m4087. Go to original source... Go to PubMed...
    4. Burus T, Lei F, Huang B, Christian WJ, Hull PC, Ellis AR, et al. Undiagnosed cancer cases in the US during the first 10 months of the COVID-19 pandemic. JAMA Oncol. 2024;10(4):500-7.
    5. Soni MM, Mamdouh HM, Suliman EA. Impact of COVID-19 Pandemic on utilization of healthcare services and spending patterns in Dubai, United Arab Emirates: a cross-sectional study. Healthcare (Basel). 2024 Feb 14;12(4):473. doi: 10.3390/healthcare12040473. Go to original source... Go to PubMed...
    6. Fedewa SA, Jessica Star MA, Priti B, Adair M, Xuesong H, Robin Y, et al. Changes in cancer screening in the US during the COVID-19 pandemic. JAMA Netw Open. 2022 Jun 1;5(6):e2215490. doi: 10.1001/jamanetworkopen.2022.15490. Go to original source...
    7. Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al, editors. AJCC cancer staging manual. 8th ed. Chicago: American College of Surgeons; 2018.
    8. Chen RC, Haynes K, Du S, Barron J, Katz AJ. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 2021;7(6):878-84.
    9. Solla Negrao EM, Cabello C, Conz L, Mauad EC, Zeferino LC, Vale DB. The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area. J Med Screen. 2023;30(1):42-6.
    10. Zhou JZ, Kane S, Ramsey C, Akhondzade M, Banerjee A, Shatsky R, et al. Comparison of early- and late-stage breast and colorectal cancer diagnoses during vs before the COVID-19 pandemic. JAMA Netw Open. 2022 Feb 1;5(2):e2148581. doi: 10.1001/jamanetworkopen.2021.48581. Go to original source... Go to PubMed...
    11. Malmgren JA, Guo B, Atwood MK, Hallam P, Roberts LA, Kaplan HG. COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021. Breast Cancer Res Treat. 2023;202(1):105-15.
    12. Howdle G, Stephanou A, Barrett J, Roushdy S, Ngui N, Hughes M, et al. Has the COVID-19 pandemic resulted in more advanced breast cancer? A hospital-based retrospective study. ANZ J Surg. 2024;94(9):1539-44.
    13. Li T, Nickel B, Ngo P, McFadden K, Brennan M, Marinovich ML, et al. A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis. Breast. 2023;67:78-88.
    14. Star J, Han X, Smith RA, Schafer EJ, Jemal A, Bandi P. Cancer screening 3 years after the onset of the COVID-19 pandemic. JAMA. 2025;333(17):1543-6.

    Return to the content